Advertisement
Life-Sciences-USA.com
The Transatlantic Life Sciences Web Portal
This is a free web portal for the life sciences in North America, Europe and Israel... » read more
- DeepCure Closes $24m Series A-1 Led by IAG Capital Partners (2024-04-11)
Series A-1 financing will advance programs in immunology and inflammation, and expand AI and automation capabilities for small molecule drug discovery DeepCure, a leader in developing novel, small molecule therapeutics powered by AI and automation of chemistry... - FundaMental Appoints Dirk Beher as CEO & Adds Investor NVF (2024-04-11)
> Highly experienced biotech executive, with over a quarter of a century of CNS drug discovery experience > Dr. Beher takes over the role of Chief Executive Officer from co-founder Dr. Thomas Schulze > FundaMental Pharma recently raised additional seed fundin... - Orgenesis & Germfree: Asset Purchase & Strategic Partnership (2024-04-10)
Germfree, a leading innovator in modular cleanroom infrastructure and services, and Orgenesis Inc. (Nasdaq: ORGS), a global leader in decentralizing cell and gene therapies (CGTs), today announced an asset purchase and strategic partnership aimed at advancing Orgen... - Vertex to Acquire Alpine Immune Sciences for $4.9b in Cash (2024-04-10)
- Alpine is a clinical stage biotechnology company focused on discovering and developing innovative, protein-based immunotherapies - - Alpine’s lead product, povetacicept, demonstrated best-in-class potential in patients with IgA nephropathy (IgAN); Phase 3 to... - Seaport Therapeutics Launches with $100m Series A Financing (2024-04-09)
> Daphne Zohar, Founding CEO of PureTech Health and Co-Founder of Karuna Therapeutics, is Founder, Chief Executive Officer and Member of the Board of Directors of Seaport > Steven M. Paul, M.D., former CEO and Chair of Karuna Therapeutics, President of Lilly Res... - Boehringer Ingelheim BioChina Able to Supply EU & US Markets (2024-04-09)
Boehringer Ingelheim Biopharmaceuticals China (BioChina), in collaboration with a customer, has successfully passed pre-approval inspections by the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). As a result, the customer is now... - Basilea: FDA Approves Antibiotic Zevtara in 3 Indications (2024-04-04)
Ad hoc announcement pursuant to Art. 53 LR Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today that the US Food a... - EnteroBiotix Completes £27m Financing Round (2024-04-04)
EnteroBiotix Limited, a clinical-stage biotechnology company focussed on developing best-in-class full-spectrum microbiome therapeutics, today announced that the Company has completed its £27m ($34m USD) funding round, supported by new and existing investors. The ... - Biognosys and Alamar Biosciences Forge Strategic Partnership (2024-04-04)
> Strategic partnership expands Biognosys’ services to include Alamar’s NULISA assays as well as joint scientific research in biofluid-based proteomics > Complementary value of Biognosys’ DIA-MS unbiased proteomics platform and Alamar’s game-changing imm... - Genmab to Acquire ProfoundBio for $1.8b in Cash (2024-04-03)
> Genmab to acquire ProfoundBio for USD 1.8 billion in cash > Acquisition will give Genmab worldwide rights to three candidates in clinical development, including rinatabart sesutecan (Rina-S), plus ProfoundBio’s novel antibody-drug conjugate (ADC) technology ...
Life-Sciences-USA.com is your doorway to the Transatlantic life sciences!
[LSUS] provides free, up-to-date and structured access to
– News
– Products
– Persons
– Organisations
– Financings
– Collaborations
in the North America, Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSUS] is 100% Made in Germany!
» Start here with the latest News!Advertisement
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top